Simon Dumesnil serves as Executive at Pasithea Therapeutics Corp., where they oversee executive responsibilities. Since joining the company, Simon Dumesnil has executed 3 insider transactions totaling $25.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 28, 2025 involved purchasing 33,333 shares valued at $25.0K.
Simon Dumesnil currently holds 35,833 shares of Pasithea Therapeutics Corp. (KTTA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Simon Dumesnil has been a net buyer of KTTA stock. They have purchased $25.0K and sold $0 worth of shares.
Simon Dumesnil's most recent insider trade was on Nov 28, 2025, when they purchased 33,333 shares at $0.75 per share.
Get notified when new Form 4 filings are submitted
| $1.06 |
| Discretionary |
| Nov 15, 2022 | KTTA | $10.7K | Award | 10,000 | $1.07 | Discretionary |